Anifrolumab trials for Systemic Lupus Erythematosus

All Anifrolumab trials · All Systemic Lupus Erythematosus trials

Phase breakdown

Recruiting trials studying Anifrolumab for Systemic Lupus Erythematosus

• A Study to Evaluate the Treatment Outcomes of Subcutaneous Anifrolumab in Immunosuppressant-naïve and Biologic-naïve Systemic Lupus Erythematosus
  NCT07430306 · Phase: Phase 3 · Ages: 18 Years to 70 Years · Sex: All (male and female) · 107 locations
• An Efficacy and Safety Study of Intravenous Anifrolumab to Treat Systemic Lupus Erythematosus in Pediatric Participants
  NCT05835310 · Phase: Phase 3 · Ages: 5 Years to 17 Years · Sex: All (male and female) · 100 locations
• Anifrolumab Malignancy and Serious Infections Study
  NCT07000110 · Phase: Not specified · Ages: 18 Years to 130 Years · Sex: All (male and female) · 4 locations
• Prospective Registry Investigating Maternal and Infant Outcomes in Anifrolumab Users
  NCT06659029 · Phase: Not specified · Ages: No age limits stated · Sex: Female · 1 location
• Prospective Registry Investigating Maternal, Infant, and Lactation Outcomes in Anifrolumab Users
  NCT06594068 · Phase: Phase 4 · Ages: 18 Years to 130 Years · Sex: Female · 1 location
• The Anifrolumab PRIM Program
  NCT06795893 · Phase: Not specified · Ages: No age limits stated · Sex: Female · 1 location
• The Role of Anifrolumab in Improving Markers of Vascular Risk in Patients With Systemic Lupus Erythematosus (SLE) - IFN-CVD
  NCT05440422 · Phase: Phase 2 · Ages: 18 Years to 80 Years · Sex: All (male and female) · 1 location

Common questions

How many trials study Anifrolumab for Systemic Lupus Erythematosus?

7 recruiting trials.

Is this list complete?

No. For the full record, search ClinicalTrials.gov.